SENSEONICSHOLDINGS,INC. (NYSEMKT:SENS) Files An 8-K Results of Operations and Financial Condition
Item 2.02.Results of Operations and Financial Condition.
On January 5, 2017, Senseonics Holdings, Inc. (the Company)
issued a press release announcing selected preliminary and
unaudited financial results for the quarter and year
endedDecember 31, 2016, as well as financial guidance for
2017.This press release has been furnished as Exhibit 99.1 to
this Current Report on Form 8-K and is incorporated herein by
The information in this Current Report on Form 8-K, including
Exhibit 99.1 attached hereto, is being furnished and shall not be
deemed filed for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the Exchange Act) or otherwise
subject to the liabilities of that section. The information
contained herein and in the accompanying exhibit is not
incorporated by reference in any filing of the Company under the
Securities Act of 1933, as amended, or the Exchange Act, whether
made before or after the date hereof and irrespective of any
general incorporation language in any filings.
Item9.01Financial Statements and Exhibits.
Press release of Senseonics Holdings, Inc. dated
About SENSEONICS HOLDINGS, INC. (NYSEMKT:SENS)
Senseonics Holdings, Inc., formerly ASN Technologies, Inc., is a medical technology company. The Company is focused on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed to be an implantable CGM system to continually measure glucose levels in people with diabetes for a period of approximately 90 days. Eversense consists of three components: a small sensor inserted subcutaneously in the upper arm by a healthcare provider; an external removable smart transmitter that receives, assesses and relays the data from the sensor and also provides vibratory alerts, and a mobile application that receives data from the transmitter and provides real-time glucose readings, alerts and other data on the user’s mobile device, such as a smartphone, Apple Watch or tablet. SENSEONICS HOLDINGS, INC. (NYSEMKT:SENS) Recent Trading Information
SENSEONICS HOLDINGS, INC. (NYSEMKT:SENS) closed its last trading session up +0.16 at 2.84 with 159,651 shares trading hands.